CD160 and plasma cell myeloma: Changes in T cell dynamics perhaps begin much earlier during the process of disease development in MM [26]; we also observed an increased presence of CD8+ T cells expressing inhibitory receptors like CD152, CD160 and CD279 indicating suppression of productive CD8+ T cell response in multiple myeloma [27].